静脈内注入用アレンドロナート組成物

Title:

静脈内注入用アレンドロナート組成物

Document Type and Number:

Japanese Patent JP3962429

Kind Code:

B2

Abstract:

Disclosed is a therapy protocol for treating patients having metastatic bone disease, hypercalcemia of malignancy and/or metabolic bone disease by administering an intravenous, citrate-buffered formulation of alendronate which is isotonic with human blood.

More Like This:

JP2013155142	BITTER-MASKED ORAL SOLUTION OF QUINOLONE-BASED ANTIMICROBIAL AGENT
WO/2003/037314	MEDICAL COMPOSITIONS FOR INTRAVESICAL TREATMENT OF BLADDER CANCER
JP3208166	STABILIZATION OF AMINO ACID-CONTAINING INFUSION

Inventors:

Brenner, the erald es
Gangnam, Miuser M

Application Number:

JP50823396A

Publication Date:

August 22, 2007

Filing Date:

August 21, 1995

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MERCK & COMPANY INCOPORATED

International Classes:

A61K9/08; A61K9/00; A61K31/663; A61K31/66; A61K47/02; A61K47/04; A61K47/12; A61P3/02; A61P19/08; A61P19/10; A61P35/00; A61P43/00

Domestic Patent References:

JP3101684A
JP3500882A

Foreign References:

WO1993011774A1
WO1994014455A1
US4814326

Other References:

幸保文治「注射薬便覧」、株式会社南山堂、1976年、1~5頁

Attorney, Agent or Firm:

Yoshio Kawaguchi
Akio Ichiiri
Makoto Ono
Katsuma Osaki

Previous Patent: セメント加速混合物

Next Patent: 脂肪酸アシル化蛋白質のゲル化削減法